{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:45:49Z","timestamp":1768437949436,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11845-018-1832-z","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T16:36:25Z","timestamp":1526402185000},"page":"59-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Where youth matters\u2014clinicopathologic characteristics and emerging trends in treatment and outcomes in young Irish women with breast cancer"],"prefix":"10.1007","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9635-9541","authenticated-orcid":false,"given":"Megan","family":"Greally","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kielty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey A.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Malouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda","family":"McSorley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niamh","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecily","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enda W.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Gullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Crown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth S.","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice M.","family":"Walshe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"1832_CR1","first-page":"7","volume":"16","author":"BF Hankey","year":"1994","unstructured":"Hankey BF, Miller B, Curtis R et al (1994) Trends in breast cancer in younger women in contrast to older women. J Natl Cancer Inst 16:7\u201314","journal-title":"J Natl Cancer Inst"},{"key":"1832_CR2","unstructured":"Ries LAG, Eisner MP, Kosary C, et al. (2005) SEER Cancer Statistics Review, 1975\u20132002, National Cancer Institute. Bethesda, MD, \n                    http:\/\/seer.cancer.gov\/csr\/1975_2002\/\n                    \n                  , based on November 2004 SEER data submission, posted to the SEER web site 2005"},{"issue":"22","key":"1832_CR3","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1093\/jnci\/djn344","volume":"100","author":"LA Brinton","year":"2008","unstructured":"Brinton LA, Sherman ME, Carreon JD, Anderson WF (2008) Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst 100(22):1643\u20131648. \n                    https:\/\/doi.org\/10.1093\/jnci\/djn344","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"1832_CR4","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1001\/jama.2013.776.","volume":"309","author":"RH Johnson","year":"2013","unstructured":"Johnson RH, Chien FL, Bleyer A (2013) Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. J Am Med Assoc 309(8):800\u2013805. \n                    https:\/\/doi.org\/10.1001\/jama.2013.776.","journal-title":"J Am Med Assoc"},{"issue":"1","key":"1832_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166.","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics. CA Cancer J Clin 63(1):11\u201330. \n                    https:\/\/doi.org\/10.3322\/caac.21166.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"1832_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0022-4804(03)00179-3","volume":"113","author":"MA Maggard","year":"2003","unstructured":"Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY (2003) Do young breast cancer patients have worse outcomes? J Surg Res 113(1):109\u2013113","journal-title":"J Surg Res"},{"key":"1832_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-383","volume":"11","author":"EAH Kheirelseid","year":"2011","unstructured":"Kheirelseid EAH, Boggs JM, Curran C et al (2011) Younger age as a prognostic indicator in breast cancer: a cohort study. BMC Cancer 11:383. \n                    https:\/\/doi.org\/10.1186\/1471-2407-11-383","journal-title":"BMC Cancer"},{"issue":"3","key":"1832_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","volume":"208","author":"JL Gnerlich","year":"2009","unstructured":"Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA (2009) Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease. J Am Coll Surg 208(3):341\u2013337. \n                    https:\/\/doi.org\/10.1016\/j.jamcollsurg.2008.12.001","journal-title":"J Am Coll Surg"},{"issue":"8852","key":"1832_CR9","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/0140-6736(93)92407-K","volume":"341","author":"A Rochefordiere de la","year":"1993","unstructured":"de la Rochefordiere A, Asselain B, Campana F et al (1993) Age as prognostic factor in premenopausal breast carcinoma. Lancet 341(8852):1039\u20131043","journal-title":"Lancet"},{"issue":"2","key":"1832_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/ijc.2910620205","volume":"62","author":"P Bonnier","year":"1995","unstructured":"Bonnier P, Romain S, Charpin C, Lejeune C, Tubiana N, Martin PM, Piana L (1995) Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer 62(2):138\u2013144","journal-title":"Int J Cancer"},{"issue":"11","key":"1832_CR11","doi-asserted-by":"publisher","first-page":"e7695","DOI":"10.1371\/journal.pone.0007695","volume":"4","author":"H Fredholm","year":"2009","unstructured":"Fredholm H, Eaker S, Frisell J, Holmberg L, Fredriksson I, Lindman H (2009) Breast cancer in young women: poor survival despite intensive treatment. PLoS One 4(11):e7695. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0007695","journal-title":"PLoS One"},{"issue":"4","key":"1832_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11864-015-0334-8","volume":"16","author":"D Ribnikar","year":"2015","unstructured":"Ribnikar D, Ribeiro JM, Pinto D, Sousa B, Pinto AC, Gomes E, Moser EC, Cardoso MJ, Cardoso F (2015) Breast cancer under age 40: a different approach. Curr Treat Options in Oncol 16(4):16. \n                    https:\/\/doi.org\/10.1007\/s11864-015-0334-8","journal-title":"Curr Treat Options in Oncol"},{"issue":"4","key":"1832_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1186\/s13058-014-0427-5","volume":"16","author":"HA Azim","year":"2014","unstructured":"Azim HA, Partridge AH (2014) Biology of breast cancer in young women. Breast Cancer Res 16(4):427. \n                    https:\/\/doi.org\/10.1186\/s13058-014-0427-5","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1832_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/bcr3156","volume":"14","author":"TH Keegan","year":"2012","unstructured":"Keegan TH, DeRouen MC, Press DJ et al (2012) Occurrence of breast cancer subtypes in adolescent and young adult women. Breast Cancer Res 14(2):55. \n                    https:\/\/doi.org\/10.1186\/bcr3156","journal-title":"Breast Cancer Res"},{"key":"1832_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/1756-0500-5-376","volume":"5","author":"M Yanagawa","year":"2012","unstructured":"Yanagawa M, Ikemot K, Kawauchi S, Furuya T, Yamamoto S, Oka M, Oga A, Nagashima Y, Sasaki K (2012) Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of a mixture of tumours with different genotype. BMC Res Notes 5:376. \n                    https:\/\/doi.org\/10.1186\/1756-0500-5-376","journal-title":"BMC Res Notes"},{"issue":"10","key":"1832_CR16","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","volume":"28","author":"KD Voduc","year":"2010","unstructured":"Voduc KD, Cheang MC, Tyldesley S et al (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28(10):1684\u20131691. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.24.9284","journal-title":"J Clin Oncol"},{"issue":"3","key":"1832_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10549-011-1872-9","volume":"131","author":"LC Collins","year":"2012","unstructured":"Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH (2012) Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat 131(3):1061\u20131066. \n                    https:\/\/doi.org\/10.1007\/s10549-011-1872-9","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"1832_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.breast.2010.01.002","volume":"19","author":"LM Bacchi","year":"2010","unstructured":"Bacchi LM, Corpa M, Santos PP, Bacchi CE, Carvalho FM (2010) Estrogen receptor-positive breast carcinomas in younger women are different from those of older women: a pathological and immunohistochemical study. Breast 19(2):137\u2013141. \n                    https:\/\/doi.org\/10.1016\/j.breast.2010.01.002","journal-title":"Breast"},{"issue":"3","key":"1832_CR19","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12253-011-9381-z","volume":"17","author":"A Caldarella","year":"2011","unstructured":"Caldarella A, Crocetti E, Bianchi S, Vezzosi V, Urso C, Biancalani M, Zappa M (2011) Female breast cancer status according to ER, PR and HER2 expression: a population based analysis. Pathol Oncol Res 17(3):753\u2013758. \n                    https:\/\/doi.org\/10.1007\/s12253-011-9381-z","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"1832_CR20","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1186\/bcr2128","volume":"10","author":"RM Tamimi","year":"2008","unstructured":"Tamimi RM, Baer HJ, Marotti J et al (2008) Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res 10(4):R67. \n                    https:\/\/doi.org\/10.1186\/bcr2128","journal-title":"Breast Cancer Res"},{"issue":"21","key":"1832_CR21","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","volume":"295","author":"LA Carey","year":"2006","unstructured":"Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MCU, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Caroline breast cancer study. JAMA 295(21):2492\u20132502","journal-title":"JAMA"},{"issue":"13","key":"1832_CR22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/jnci\/djt134","volume":"105","author":"E Copson","year":"2013","unstructured":"Copson E, Eccles B, Maishman T, Gerty S, Stanton L, Cutress RI, Altman DG, Durcan L, Simmonds P, Lawrence G, Jones L, Bliss J, Eccles D, POSH Study Steering Group (2013) Prospective observational study of breast cancer treatment outcomes for UK women aged 18-40 years at diagnosis: the POSH study. J Natl Cancer Inst 105(13):978\u2013988. \n                    https:\/\/doi.org\/10.1093\/jnci\/djt134","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1832_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2147\/JMDH.S49994.","volume":"29","author":"C Reyna","year":"2014","unstructured":"Reyna C, Lee MC (2014) Breast cancer in young women: special considerations in multidisciplinary care. J Multidiscip Healthc 29(7):419\u2013429. \n                    https:\/\/doi.org\/10.2147\/JMDH.S49994.","journal-title":"J Multidiscip Healthc"},{"key":"1832_CR24","volume-title":"AJCC cancer staging manual","author":"SB Edge","year":"2010","unstructured":"Edge SB, Byrd DR, Compton CC et al (2010) AJCC cancer staging manual. Springer, New York"},{"issue":"9472","key":"1832_CR25","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG)","year":"2005","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365(9472):1687\u20131717","journal-title":"Lancet"},{"issue":"4","key":"1832_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/path.1916","volume":"208","author":"EA Rakha","year":"2006","unstructured":"Rakha EA, Putti TC, Abd El-Rehim DM et al (2006) Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. J Pathol 208(4):495\u2013506","journal-title":"J Pathol"},{"issue":"1","key":"1832_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/ijc.22625","volume":"121","author":"MW Louwman","year":"2007","unstructured":"Louwman MW, Vriezen M, van Beek MW et al (2007) Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands. Int J Cancer 121(1):127\u2013135","journal-title":"Int J Cancer"},{"issue":"3","key":"1832_CR28","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.molonc.2010.04.004","volume":"4","author":"B Weigelt","year":"2010","unstructured":"Weigelt B, Geyer FC, Reis-Filho JS (2010) Histological types of breast cancer: how special are they? Mol Oncol 4(3):192\u2013208. \n                    https:\/\/doi.org\/10.1016\/j.molonc.2010.04.004","journal-title":"Mol Oncol"},{"issue":"Suppl 3","key":"1832_CR29","doi-asserted-by":"publisher","first-page":"S566","DOI":"10.1245\/s10434-015-4591-3.","volume":"22","author":"I Lizarraga","year":"2015","unstructured":"Lizarraga I, Schroeder MC, Weigel RJ, Thomas A (2015) Surgical management of breast cancer in 2010-2011 SEER registries by hormone and HER2 receptor status. Ann Surg Oncol 22(Suppl 3):S566\u2013S572. \n                    https:\/\/doi.org\/10.1245\/s10434-015-4591-3.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"1832_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jamasurg.2013.3049","volume":"149","author":"S Agarwal","year":"2014","unstructured":"Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J (2014) Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg 149(3):267\u2013274. \n                    https:\/\/doi.org\/10.1001\/jamasurg.2013.3049","journal-title":"JAMA Surg"},{"issue":"1","key":"1832_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10549-009-0388-z","volume":"119","author":"W Han","year":"2010","unstructured":"Han W, Kang SY, Korean Breast Cancer Society (2010) Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Breast Cancer Res Treat 119(1):193\u2013200. \n                    https:\/\/doi.org\/10.1007\/s10549-009-0388-z","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"1832_CR32","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.breast.2015.04.002","volume":"24","author":"R Deus Moura de","year":"2015","unstructured":"de Deus Moura R, Carvalho M, Bacchi CE (2015) Breast cancer in very young women: clinicopathological study of 149 patients \u226425 years old. Breast 24(4):461\u2013467. \n                    https:\/\/doi.org\/10.1016\/j.breast.2015.04.002","journal-title":"Breast"},{"issue":"10","key":"1832_CR33","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama\/2017\/11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA 318(10):918\u2013926. \n                    https:\/\/doi.org\/10.1001\/jama\/2017\/11470","journal-title":"JAMA"},{"issue":"4","key":"1832_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/cncr.20022","volume":"100","author":"N Kroman","year":"2004","unstructured":"Kroman N, Holtveg H, Wohlfahrt J, Jensen MB, Mouridsen HT, Blichert-Toft M, Melbye M (2004) Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer 100(4):688\u2013693","journal-title":"Cancer"},{"issue":"5","key":"1832_CR35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ijrobp.2011.10.075","volume":"83","author":"U Mahmood","year":"2012","unstructured":"Mahmood U, Morris C, Neuner G, Koshy M, Kesmodel S, Buras R, Chumsri S, Bao T, Tkaczuk K, Feigenberg S (2012) Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Int J Radiat Oncol Biol Phys 83(5):1387\u20131393. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2011.10.075","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1832_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3322\/caac.21289","volume":"65","author":"MK Barton","year":"2015","unstructured":"Barton MK (2015) Mastectomy and breast-conserving therapy confer equivalent outcomes in young women with early-stage breast cancer. CA Cancer J Clin 65(5):335\u2013336. \n                    https:\/\/doi.org\/10.3322\/caac.21289","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1832_CR37","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10549-014-3125-1","volume":"147","author":"W Sheridan","year":"2014","unstructured":"Sheridan W, Scott T, Caroline S, Yvonne Z, Vanessa B, David V, Karen G, Stephen C (2014) Breast cancer in young women: have the prognostic implications of breast cancer subtypes changed over time? Breast Cancer Res Treat 147(3):617\u2013629. \n                    https:\/\/doi.org\/10.1007\/s10549-014-3125-1","journal-title":"Breast Cancer Res Treat"},{"key":"1832_CR38","doi-asserted-by":"publisher","first-page":"325715","DOI":"10.1155\/2015\/325715","volume":"2015","author":"MK Lee","year":"2015","unstructured":"Lee MK, Varzi LA, Chung DU et al (2015) The effect of young age in hormone receptor positive breast cancer. Biomed Res Int 2015:325715. \n                    https:\/\/doi.org\/10.1155\/2015\/325715","journal-title":"Biomed Res Int"},{"issue":"7233","key":"1832_CR39","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","volume":"320","author":"N Kroman","year":"2003","unstructured":"Kroman N, Jensen MB, Wohlfahrt J et al (2003) Factors influencing the effect of age on prognosis in breast cancer: population based study. BMJ 320(7233):474\u2013478","journal-title":"BMJ"},{"issue":"2","key":"1832_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/annonc\/mdu544","volume":"26","author":"M Gnant","year":"2015","unstructured":"Gnant M, Mlineritsch B, Stoeger H (2015) Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozole plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian breast and colorectal cancer study group trial 12. Ann Oncol 26(2):313\u2013320. \n                    https:\/\/doi.org\/10.1093\/annonc\/mdu544","journal-title":"Ann Oncol"},{"issue":"27","key":"1832_CR41","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N (2004) A multigene assay to predict recurrence of tamoxifen-treated, node negative breast cancer. N Engl J Med 351(27):2817\u20132826","journal-title":"N Engl J Med"},{"issue":"3","key":"1832_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.breast.2014.03.011","volume":"23","author":"AH Partridge","year":"2014","unstructured":"Partridge AH, Pagoni O, Abulkhair O et al (2014) First international consensus guidelines for breast cancer in young women (BCY1). Breast 23(3):209\u2013220. \n                    https:\/\/doi.org\/10.1016\/j.breast.2014.03.011","journal-title":"Breast"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11845-018-1832-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-018-1832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-018-1832-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T21:21:37Z","timestamp":1567891297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11845-018-1832-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s11845-018-1832-z","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"assertion":[{"value":"18 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Janice M. Walshe has served as consultant in an advisory role to Roche, Genomic Health, Pfizer. Dr. Giuseppe Gullo has served as a consultant in an advisory role to Roche, Novartis, BMS.There are no other potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}